Live Breaking News & Updates on Hospital De Parapl

Stay updated with breaking news from Hospital de parapl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

16 patients have been enrolled in a multicenter international, randomized, placebo-controlled, double-blinded Phase II clinical trial Goal: to determine the. ....

United States , Noord Holland , Claus Andersen , Antonio Oliviero , Erik Wolters , Netherlands Enterprise Agency , Brightlands Agrifood Fund , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Professor Fin Biering S , Phd Claus Andersen , Principal Investigator , Johannes De Munter , Lumana Invest , Brightlands Venture Partners , Netherlands Enterprise , Hospital De Parapl , Nacional De Parapl , Venture Partners , Chemelot Ventures , Dutch Ministry , Economic Affairs , Spring Lifesciences Communication ,

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells treatment for Traumatic Spinal Cord Injury

Neuro-Cells treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following traumaThe randomized, placebo-controlled, international multi-center ....

United States , Noord Holland , Kostenloser Wertpapierhandel , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Agencia Espanola De Medicamentos , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest ,

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury

Neuro-Cells® treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following trauma The randomized,. ....

United States , Noord Holland , Agencia Espa , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest , Brightlands Venture Partners ,